Experience

ABM Therapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Associate Director, Clinical Project Management

  • 2023 - Present



Infectious Disease Research Institute (now Access to Advanced Health Institute)

• United States
• Biotechnology Research
• 1 - 100 Employee

• Senior Clinical Operations Manager

  • Aug 2020 - Mar 2023



Omeros Corporation

• United States
• Biotechnology Research
• 100 - 200 Employee

• Clinical Program Manager

  • Feb 2018 - Dec 2019



Spiration, Inc. dba Olympus Respiratory America

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Clinical Project Manager

  • Feb 2014 - Jan 2018

  Management of day to day operations of the China SVS emphysema registration trial. Procedural support for device for lobar occlusion.

• Clinical Field Specialist

  • Jun 2013 - Jan 2014

  Procedural support , device



Light Sciences Oncology

• Clinical Project Manager

  • Jan 2009 - Feb 2013

  About Light Sciences OncologyLight Sciences Oncology (LSO) is developing Aptocine™ (talaporfin sodium) for solid tumors as well as other indications such as BPH. Aptocine is a water-soluble drug targeted by a small, single-use, disposable drug activator included with the drug. Aptocine is designed to provide tolerable, effective, and repeatable treatments for patients. LSO has completed treatment of patients in a Phase 3 trial of Aptocine in hepatocellular carcinoma (HCC), a Phase 3 trial for metastatic colorectal cancer (MCRC) and in Phase 1 and Phase 2 clinical trials in benign prostatic hyperplasia (BPH), or enlargement of the prostate. The company has positioned Aptocine to benefit an increasing number of patients with a strong portfolio of intellectual property, innovative applications in development, and an exceptionally capable and efficient team.Aptocine has three potential primary mechanisms of action: direct tumor cytotoxicity, apoptosis due to vascular shutdown, and anti-tumor immune stimulation. In clinical studies to date, Aptocine has been well-tolerated with no evidence that Aptocine causes the serious toxicities associated with traditional cancer treatments. Show less

• Sr. CRA

  • Oct 2007 - Jan 2009



Pnc Labs, Inc.

• Director

  • Sep 2004 - Jan 2012

  About PNC LABS PNC LABS, INC., a subsidiary of NT Holding Corp. is a nutritional supplements company serving the preventive and alternative healthcare segments, and looking to expand through an acquisition with organic growth strategy. The company is selectively evaluating niche companies in order to provide quality nutraceuticals to consumers. The company further plans to be fully integrated in manufacturing, distribution and marketing. The company says it is in discussions with several acquisition candidates. PNC LABS is targeting companies with less than $5 million in annual sales. Show less



Nt Holding Corp. Inc.

• CEO

  • Jul 2003 - May 2008

  Formally Abss.ob About NT Holding Corp. NTHH.ob NT Holding Corp., NT standing for "new technologies", is a publicly traded holding company looking to merge with or acquire operating business entities through a variety of business combinations. NT will function as an advocate and accelerator for entrepreneurs and scientists, creating a network of people and companies working together to help support and develop new initiatives. These can be in the form of new or emerging growth companies, or new directions, projects, or products within existing structures. Show less



Nano Superlatice

• Taipei City, Taiwan

• Chief Operating Officer

  • Jan 2006 - Oct 2007

  About Nano Superlatice: Nano (NSLT.OB) utilizes Arc Bond Sputtering and Superlattice technology to apply multi-layers of super-hard elemental coatings on an array of precision products to achieve a variety of physical properties. The application of the coating on industrial products is designed to change their physical properties, improving a product's durability, resistance, chemical and physical characteristics as well as performance. Nano's (NSLT.OB) super-hard alloy coating materials were especially developed for printed circuit board drills in response to special market requirements Show less



Iris Inc.

• New York

• Clinical Director

  • Jan 2006 - Feb 2007

  Iris Inc is a boutique company catering to the Pharmaceutical companies. It handles databases, electronic data managment, and IVRS systems. Iris Inc is a boutique company catering to the Pharmaceutical companies. It handles databases, electronic data managment, and IVRS systems.



Parexel

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Regional project manager

  • Aug 2004 - 2006



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Regional Project Manager

  • Apr 2002 - 2004



Acorda Therapeutics, Inc.

• United States
• Biotechnology Research
• 100 - 200 Employee

• Sr. CRA

  • Jan 2000 - Feb 2002



Memorial Sloan Kettering Cancer Center

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Clinical Research Database Associate

  • 1997 - Dec 1999



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Clinical Research Associate

  • Jan 1993 - 1997